The future of HPAPIs according to industry insiders
High potency APIs are becoming a key focus of the pharmaceutical business, with drug makers from all areas racing to establish a foothold in the market.
Archives for November 29, 2011
China-focused USP committee to develop excipient standards
USP is creating a China-focused East Asia expert committee to develop quality standards for excipients.
USPTO rejects MonoSol claims in delivery film patent fight with BDSI
The USPTO has rejected MonoSol RX’s claims that production methods for a cancer pain patch developed by BioDelivery Sciences (BDSI) infringe on manufacturing techniques it uses to make its own drug delivery films.
UBC looking to ‘buy or build’ to serve strategic partnerships
UBC expects strategic outsourcing of outcomes and personalised medicine research to accelerate as biopharm cut fixed costs.
Analysts back CMO Arch’s IPO on CRAMS biz potential
An expanding CRAMS business and bulk drug strength makes Indian CMO Arch Pharmalabs’ IPO a solid investment, analysts report.